多酶纳米颗粒作为癌症免疫疗法免疫疗法的高效 Pyroptosis 和免疫细胞死亡诱导剂
Hekai Yang1, Guangzhao Xu1,2, Fahui Li1
1School of Pharmacy, Shandong Second Medical University, Weifang, 261053, China.
Advanced science (Weinheim, Baden-Wurttemberg, Germany)
|October 9, 2024
概括
这项研究介绍了IMZF,它是一种纳米级的火灭菌诱导剂,通过产生氧和活性氧物种来对抗"冷"瘤. 它逆转免疫抑制,增强免疫治疗对初级和远端瘤的疗效.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 纳米技术纳米技术
- 生物化学 生物化学
背景情况:
- 免疫疗法在瘤学中至关重要,但受到"冷"瘤微环境 (TME) 的限制,免疫反应不足.
- 在TME中克服免疫抑制对于有效的癌症治疗至关重要.
研究的目的:
- 开发一种能够逆转"冷"瘤中的免疫抑制的多功能纳米级热诱导剂 (IMZF).
- 研究IMZF在增强免疫疗法的治疗潜力.
主要方法:
- 设计了IMZF,一种具有超氧化物脱酶 (SOD),催化酶 (CAT),过氧化酶 (POD) 和谷氨氧化酶 (GSHOx) 活性的纳米剂.
- IMZF被评估为其产生氧气,活性氧物种 (ROS) 和耗尽TME内的谷氨 (GSH) 的能力.
- 这项研究评估了IMZF诱导免疫细胞死亡 (ICD) 和热的能力,促进巨细胞两极分化和免疫细胞透.
主要成果:
- IMZF在酸性和富含谷氨的TME中解离,表现出强烈的酶级联活性.
- 通过IMZF产生氧气缓解了瘤缺氧,并促进了M2到M1巨细胞的两极分化.
- IMZF诱导ICD和热,增强树突细胞成熟和炎性淋巴细胞透,从而逆转TME免疫抑制并抑制初级和远端瘤.
结论:
- 基于级联酶平台的激素灭菌诱导剂 (IMZF) 有效地克服了"冷"瘤中的免疫抑制.
- 在瘤学中,IMZF为先进的免疫治疗干预提供了一个有希望的策略.
- 这种方法协同增强了抗瘤免疫反应.
更多相关视频
08:02In Vivo Immunogenicity Screening of Tumor-Derived Extracellular Vesicles by Flow Cytometry of Splenic T Cells
Published on: September 23, 2021
2.5K
09:01Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy
Published on: May 22, 2020
3.1K
相关概念视频
01:27Tumor Immunotherapy
488
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
488
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K